Fongit

Fongit is a startup incubator and accelerator located in Geneva, Switzerland, established in 1991. The organization focuses on supporting high-tech ventures, including startups, scale-ups, and small to medium-sized enterprises (SMEs) that are experiencing rapid growth. Fongit collaborates with local research institutions, universities, and higher education establishments to foster innovation, particularly in the fields of information and communications technology (ICT), engineering, and life sciences. The incubator is committed to advancing technological innovations that align with Sustainable Development Goals, thereby promoting a sustainable future through entrepreneurial efforts.

Antonio Gambardella

Director

84 past transactions

BrainScape Medical

Debt Financing in 2025
BrainScape Medical is a Swiss life sciences startup focused on developing an end-to-end solution for brain disorder management and care, addressing many limitations of current approaches.

AnimalCare Engineering

Grant in 2025
AnimalCare Engineering dedicated to enhancing the quality of life for pets through innovative health monitoring technology. Its cutting-edge devices empower pet owners and veterinarians with real-time insights, ensuring the best possible care.

EarlySight

Debt Financing in 2025
EarlySight SA is a Swiss medical device company established in 2016 and headquartered in Lausanne. It specializes in developing advanced imaging technology to aid in the early detection and treatment of eye diseases. The company's innovative eye fundus camera utilizes cellular-level imaging and transscleral illumination to provide detailed images of the retina, allowing for the detection of minor structural changes. This technology enables eye specialists to monitor treatment effects rapidly and non-invasively, enhancing their ability to visualize the morphology of retinal cells. EarlySight aims to bring its cutting-edge solutions to clinics, thereby improving patient outcomes in ophthalmology.

FlowRide

Grant in 2025
FlowRide provides a more fluid and efficient transportation alternative.

Immitra Bio

Debt Financing in 2025
Immitra Bio is a biotechnology company developing a proprietary genetic medicine platform that combines hematopoietic stem cells (HSCs) and CRISPR-Cas9 gene editing. This innovative approach enables precise, long-term gene alterations within blood stem cells, offering transformative treatments for rare blood disorders with significant unmet medical needs.

Miloo

Debt Financing in 2025
Miloo is a Swiss company specializing in high-performance electric bikes tailored for urban mobility. The company designs and assembles its vehicles in Switzerland, ensuring they meet the highest standards of safety and performance. Miloo's e-bikes are engineered to enhance the commuting experience, offering riders a stylish and powerful alternative to traditional transport methods. With a focus on sustainability and user comfort, Miloo's electric bikes provide extended range and connectivity, allowing individuals to navigate city life with ease. By combining innovative design with advanced technology, Miloo aims to redefine urban transportation, promoting a cleaner and more agile form of mobility.

Adoram Therapeutics

Pre Seed Round in 2025
Adoram Therapeutics is a biotechnology company focused on developing innovative therapies for patients with immune-based diseases and solid tumors. The company specializes in allosteric modulators, which target validated cancer immunotherapy pathways. By utilizing small molecule immunotherapy, Adoram aims to address the limitations of earlier drug generations, particularly in the context of adenosine-rich tumors. This approach enables researchers to tackle unmet medical needs within onco-immunology, offering new hope for effective treatments in challenging cancer cases.

Cerret

Funding Round in 2025
Cerret, a Swiss-based jewelry brand, specializes in designing and manufacturing smart bracelets for women's safety. Their products, equipped with advanced technology, allow users to discreetly alert loved ones or authorities in case of an emergency, providing a sense of security and peace of mind.

Effetto Venturi

Debt Financing in 2024
Effetto Venturi specializes in the production of autonomous, lightweight buoys. These buoys, equipped with electric thrusters and remote control capabilities, can maintain precise positions in water without the need for anchoring. They are designed for various applications, including temporary water separation, event management, port activities, and water monitoring.

The ShowCase

Debt Financing in 2024
The ShowCase offers revolutionary portable studio system for exhibiting luxury products.

Astrocyte

Debt Financing in 2024
Astrocyte is a brain-penetrant inhibitor to improve memory function.

Dyneo Technologies

Debt Financing in 2024
Dyneo Technologies specializes in data-driven solutions for district heating and cooling networks. The company offers a Software as a Service (SaaS) platform that helps operators enhance energy efficiency and increase the use of renewable energy sources. Dyneo's technology enables operators to identify and address performance-degrading issues at scale, while also providing autonomous optimization to improve the profitability and sustainability of their thermal networks.

Adoram Therapeutics

Debt Financing in 2024
Adoram Therapeutics is a biotechnology company focused on developing innovative therapies for patients with immune-based diseases and solid tumors. The company specializes in allosteric modulators, which target validated cancer immunotherapy pathways. By utilizing small molecule immunotherapy, Adoram aims to address the limitations of earlier drug generations, particularly in the context of adenosine-rich tumors. This approach enables researchers to tackle unmet medical needs within onco-immunology, offering new hope for effective treatments in challenging cancer cases.

Alpes-éco

Debt Financing in 2024
Alpes-éco Suisse specializes in developing smart herd management solutions for farmers. Their primary product is livestock management software, which optimizes daily animal care, including milk production control and health evaluation. The company's connected devices, accessible via smartphones, enable efficient management of livestock, even in remote areas, thereby enhancing sustainability and efficiency in the agricultural sector.

Neurovia Bioelectronics

Grant in 2024
Neurovia Bioelectronics is revolutionizing blood pressure management by offering innovative solutions to improve health outcomes and quality of life. It utilizes established microfabrication technologies and 3D manufacturing techniques to create endovascular stimulation devices

Wyss Center

Debt Financing in 2024
Epios personalized and precision management of brain disorders using daily life monitoring and therapeutics. The Epios system comprises a series of thin leads incorporating sensing electrodes and a miniature implant, inserted beneath the skin. The neural signals are wirelessly transmitted to an external receiver held in place on the skin directly over the implant with a magnet, and from there are conveyed to a wearable data processor and are finally securely stored in the Epios Cloud.

HekeTiss

Debt Financing in 2024
HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.

Azure Cell Therapies

Grant in 2024
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases

Firefly Fusion

Grant in 2024
FireFly Fusion is a research company focused on advancing fusion energy technology to create clean and sustainable power through controlled nuclear reactions. The company is pioneering the development of standard tokamaks, a type of device used to confine hot plasma and facilitate fusion. By utilizing microwaves to generate and control this plasma, FireFly Fusion aims to harness the inherent energy of fusion, positioning itself as a complementary solution to renewable energy sources. Its efforts are directed towards enabling organizations, governments, and industries to transition toward a more sustainable energy future, utilizing proven technologies combined with innovative scientific advancements.

Antion Biosciences

Debt Financing in 2024
Antion Biosciences SA is a biotechnology company based in Geneva, Switzerland, specializing in cell and gene engineering. The company focuses on developing off-the-shelf therapies to address diseases with significant unmet medical needs. Utilizing its proprietary technology, Antion enables a modular and tunable approach to multiplex engineering of therapeutic cells. Recently, the company has shifted its efforts to repurpose its miCAR19 developments for autoimmune diseases, leveraging in vivo proof-of-concept data from its lead product, miCAR7. Antion is distinguished by its allogeneic solutions and aims to deliver a best-in-class product specifically targeting B-cell-driven autoimmune diseases. With substantial preclinical advancements already achieved, the next critical step for the company is to establish proof-of-concept in human trials.

nsave

Seed Round in 2024
Nsave is a fintech startup that specializes in digital banking services, focusing on providing a secure platform for saving in various currencies, including USD, EUR, and GBP. The company aims to enhance financial inclusion by offering services that do not impose account restrictions, allowing customers to access global safe accounts for their funds. With a commitment to financial security, Nsave ensures that users can manage their savings with confidence and ease.

HeroSupport

Seed Round in 2024
HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Transmutex

Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

Carrat Sàrl

Seed Round in 2023
Carrat Sàrl is a company that makes bracelets that send an emergency call with the press of a button.

MPC Therapeutics

Debt Financing in 2023
MPC Therapeutics is a biotechnology company focused on developing innovative treatments for cancer and degenerative disorders. The company specializes in creating compounds that inhibit mitochondrial pyruvate carriers, which are designed to enhance the efficacy of T-cell therapies and address metabolic and neurodegenerative diseases. By leveraging expertise in medicinal chemistry and mitochondrial biology, MPC Therapeutics aims to modify mitochondrial processes to influence cellular conductivity, ultimately preventing disease progression and improving patient outcomes.

EarlySight

Debt Financing in 2023
EarlySight SA is a Swiss medical device company established in 2016 and headquartered in Lausanne. It specializes in developing advanced imaging technology to aid in the early detection and treatment of eye diseases. The company's innovative eye fundus camera utilizes cellular-level imaging and transscleral illumination to provide detailed images of the retina, allowing for the detection of minor structural changes. This technology enables eye specialists to monitor treatment effects rapidly and non-invasively, enhancing their ability to visualize the morphology of retinal cells. EarlySight aims to bring its cutting-edge solutions to clinics, thereby improving patient outcomes in ophthalmology.

KYLYS

Debt Financing in 2023
KYLYS is a Swiss company located in Geneva, founded in March 2017, that specializes in the development of innovative biomolecule-based products to address medical, surgical, and cosmetic needs. The company offers a unique line of hyaluronic acid pearls, which are biocompatible and biodegradable gels that can be easily injected at room temperature. These gels have the capability to form microgel structures within the tissue at body temperature, ensuring a durable effect while preventing migration from the injection site. By focusing on safety and efficacy, KYLYS aims to provide healthcare providers with effective solutions for their patients.

FluoSphera

Debt Financing in 2023
FluoSphera is a biotechnology company focused on developing safer and more effective drugs. It aims to minimize adverse side effects and reduce reliance on animal testing by leveraging innovative drug discovery technologies. This enables FluoSphera's partners to better understand human physiological responses and safeguard populations from harmful chemicals more efficiently.

Consulto

Grant in 2023
Consulto intends to change the way outpatient care is delivered by extending team-based care beyond hospital walls.

Plair SA

Debt Financing in 2023
Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

Endotelix

Debt Financing in 2023
Endotelix is a privately held Swiss biotech start-up and a spin-off from the University of Geneva, focused on developing innovative solutions for Antiphospholipid Syndrome. The company specializes in creating diagnostic products and therapies aimed at detecting circulating antibodies associated with the condition. By providing fast, sensitive, and reliable diagnostic tests, Endotelix aims to enhance healthcare outcomes for vulnerable populations, including pregnant women and adolescent children. The company is committed to reducing pregnancy-related complications and improving overall healthcare delivery through its advanced research and diagnostic tools.

Ovomind

Seed Round in 2022
Ovomind is a technology company developing smart wristbands equipped with sensors that analyze users' emotions via biosignals. These devices communicate with video games in real-time, adapting gameplay based on the wearer's emotional state. The company aims to enhance gaming experiences by incorporating emotional feedback, placing human emotion at the core of interactive entertainment.

Terapet

Debt Financing in 2022
Terapet SA is a Switzerland-based company founded in 2019 at CERN by physicists Christina Vallgren and Marcus Palm, along with Professor Raymond Miralbell from the Geneva University Hospitals. The company specializes in developing advanced proton therapy technology for cancer treatment, which allows for precise targeting of tumors while minimizing damage to surrounding healthy tissue. This innovative approach leverages the unique properties of protons, which stop at a predetermined depth within the patient, enabling the delivery of a concentrated dose to the tumor. Terapet's system also provides real-time, three-dimensional monitoring of the proton dose administered, enhancing treatment accuracy and safety. With a focus on making cutting-edge cancer therapy more accessible and cost-effective, Terapet is preparing for the market launch of its initial product.

EBAMed

Debt Financing in 2022
EBAMed SA is a Swiss startup based in Geneva that specializes in developing innovative medical devices for the non-invasive treatment of heart arrhythmias. Founded in 2018, the company focuses on creating an ultrasound-based device that utilizes proton therapy to monitor heart motion and synchronize therapeutic beams in real time. This technology allows for the precise delivery of radiation treatment to targeted heart tissues, thereby expanding treatment options for existing proton therapy centers and enabling them to treat heart patients effectively. By providing a non-invasive approach to cardiac care, EBAMed aims to improve patient outcomes and streamline treatment processes in outpatient settings.

iOnctura

Debt Financing in 2022
iOnctura is a biopharmaceutical company specializing in the development of novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which plays a significant role in cancer progression. The company seeks to enhance existing immune checkpoint therapies by creating new drugs that, when used in conjunction with these therapies, may improve safety and efficacy for cancer patients. iOnctura has formed strategic partnerships with prominent organizations, including Merck and Cancer Research Technology, to advance a pipeline of preclinical molecules toward clinical application. With access to advanced drug discovery labs and a network of academic collaborators, iOnctura is well-equipped to develop innovative combination therapies in the realm of cancer immunology, ultimately striving to optimize treatment outcomes for patients.

V-Labs

Debt Financing in 2022
V-Labs is a technology company specializing in augmented reality solutions for excavation projects. It develops advanced augmented reality technology tailored for geospatial headsets, allowing users to visualize complex data directly at the worksite with centimeter accuracy. This innovative approach includes a local positioning system that enhances operational efficiency by minimizing risks of damage to underground infrastructure. By providing real-time visual guidance, V-Labs enables operators and contractors to expedite excavation processes while ensuring safety and precision in their work.

Deasyl

Debt Financing in 2022
Deasyl is a company dedicated to the development of innovative and eco-friendly chemical solutions, focusing on green chemistry and recycling processes. It specializes in transforming waste and biomass into sustainable products, utilizing clean technology to create scalable processes for major players in the fine chemical and petrochemical industries. By advancing waste valorization and employing biodiesel production methods, Deasyl enables its clients to adopt environmentally friendly practices, thereby contributing to a more sustainable future.

GliaPharm

Debt Financing in 2022
GliaPharm SA is a Swiss biotechnology company focused on developing innovative treatments for neurological and psychiatric disorders. Established in 2016 and headquartered in Geneva, GliaPharm specializes in targeting glial cells, which are the support cells of neurons, to enhance brain metabolism in pathological conditions. The company utilizes its GliaX technology platform to identify drugs that influence glial cell activity and brain energy metabolism. This platform incorporates high throughput screening technologies, metabolic tests for in vitro and in vivo assessments, and various rodent models to study neurological diseases such as Alzheimer's disease, amyotrophic lateral sclerosis, and other psychiatric conditions. Through its research and development efforts, GliaPharm aims to provide healthcare providers with novel therapeutic options for patients suffering from these disorders, positioning itself as a leader in glia-mediated neuroprotection and cognitive function maintenance.

Transmutex

Debt Financing in 2022
Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

Impaakt

Debt Financing in 2022
Impaakt SA, established in 2017 and headquartered in Carouge, Switzerland, operates a collaborative platform that leverages collective intelligence to evaluate and report on the social and environmental impacts of companies. The company offers standardized impact reports for businesses, sectors, and Sustainable Development Goals (SDGs), along with advanced data analytics tools to facilitate informed investment decisions.

Diabeto

Grant in 2022
Diabeto is a biopharmaceutical start-up project spinning off the University of Geneva and based on pioneering expertise in discovery of mechanisms sustaining life without insulin.

ORamaVR

Debt Financing in 2022
ORamaVR is a pioneering company focused on transforming medical training through virtual reality (VR) technology. It offers an innovative IT platform, MAGES-SDK, that enables medical organizations to create high-fidelity VR simulations for training purposes at significantly reduced costs and time compared to traditional methods. These simulations are utilized by hospitals, medical schools, and training centers to effectively train and assess medical professionals. The platform's efficacy is supported by numerous clinical trials and scientific publications, with endorsements from prestigious institutions such as the USC Keck School of Medicine, NYU Langone Medical School, and the University of Geneva. ORamaVR has received multiple international awards for its societal impact and has established partnerships with notable organizations, including Airbus and Microsoft. The company has also secured significant venture capital funding from strategic investors, enhancing its position in the field of medical VR training.

Adiposs

Seed Round in 2021
Adiposs SA is a clinical-stage life science company focused on developing innovative medical imaging products aimed at improving early detection of cachexia, a severe body-wasting syndrome often associated with cancer. The company's first-in-class CT contrast product is designed to identify signs of body wasting a year before noticeable weight loss occurs, allowing healthcare providers to detect cancer at an earlier stage. This advancement not only enhances the quality of life for patients but also increases their chances of survival against cancer and other chronic diseases. Through its pioneering imaging technology, Adiposs is positioned to make a significant impact in the field of oncology and patient care.

HekeTiss

Grant in 2021
HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.

ABCDx

Convertible Note in 2021
ABCDx SA is a privately-funded company based in Geneva, Switzerland, founded in 2014 by three experts in the field of brain biomarkers. The founders include two prominent researchers from the Faculty of Medicine at the University of Geneva and the Vall d’Hebron Research Institute, who are recognized for their contributions to biomarker discovery and validation. The third founder brings extensive experience in the diagnostic and pharmaceutical industries. ABCDx specializes in the development and validation of biomarker and biomarker panel tests aimed at enhancing the diagnosis and treatment of brain injuries. The company's offerings are designed to identify and assess patients at risk of severe long-term complications stemming from traumatic injuries, strokes, and post-stroke infections. Through its innovative approach, ABCDx aims to improve patient outcomes in the realm of brain health.

Neurosoft Bioelectronics

Convertible Note in 2021
Neurosoft Bioelectronics is a Swiss company specializing in the development of soft implantable electrodes designed for interfacing with the nervous system. The company focuses on creating advanced neural implants that can record and stimulate the brain, spinal cord, and peripheral nerves, addressing the limitations of traditional stiff devices that hinder patient outcomes. Its flagship product, the SOFT ECoG, is a subdural electrode that facilitates effective brain monitoring and stimulation while minimizing electrical resistance and MRI artifacts. This innovative technology aims to achieve long-term bio-integration with neural tissues, adapting to both static and dynamic mechanical properties, which enhances therapeutic capabilities for patients suffering from neurological disorders. Ultimately, Neurosoft Bioelectronics strives to improve clinical outcomes and expand the potential applications of neural interfaces in healthcare.

The Content Engine

Debt Financing in 2021
The Content Engine is a technology platform and content agency that specializes in delivering high-quality content at scale for organizations aiming to engage global audiences. By integrating advanced machine-learning technologies with top-tier editorial and workflow processes, the company produces tailored content efficiently and effectively. Its platform is designed to streamline the entire content lifecycle, including ideation, commissioning, production, approvals, and distribution. This approach allows organizations to publish engaging content daily across various channels, enhancing their communication strategies and audience reach.

FluoSphera

Grant in 2021
FluoSphera is a biotechnology company focused on developing safer and more effective drugs. It aims to minimize adverse side effects and reduce reliance on animal testing by leveraging innovative drug discovery technologies. This enables FluoSphera's partners to better understand human physiological responses and safeguard populations from harmful chemicals more efficiently.

HeroSupport

Grant in 2021
HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Adiposs

Debt Financing in 2021
Adiposs SA is a clinical-stage life science company focused on developing innovative medical imaging products aimed at improving early detection of cachexia, a severe body-wasting syndrome often associated with cancer. The company's first-in-class CT contrast product is designed to identify signs of body wasting a year before noticeable weight loss occurs, allowing healthcare providers to detect cancer at an earlier stage. This advancement not only enhances the quality of life for patients but also increases their chances of survival against cancer and other chronic diseases. Through its pioneering imaging technology, Adiposs is positioned to make a significant impact in the field of oncology and patient care.

ORamaVR

Funding Round in 2020
ORamaVR is a pioneering company focused on transforming medical training through virtual reality (VR) technology. It offers an innovative IT platform, MAGES-SDK, that enables medical organizations to create high-fidelity VR simulations for training purposes at significantly reduced costs and time compared to traditional methods. These simulations are utilized by hospitals, medical schools, and training centers to effectively train and assess medical professionals. The platform's efficacy is supported by numerous clinical trials and scientific publications, with endorsements from prestigious institutions such as the USC Keck School of Medicine, NYU Langone Medical School, and the University of Geneva. ORamaVR has received multiple international awards for its societal impact and has established partnerships with notable organizations, including Airbus and Microsoft. The company has also secured significant venture capital funding from strategic investors, enhancing its position in the field of medical VR training.

Ovomind

Pre Seed Round in 2020
Ovomind is a technology company developing smart wristbands equipped with sensors that analyze users' emotions via biosignals. These devices communicate with video games in real-time, adapting gameplay based on the wearer's emotional state. The company aims to enhance gaming experiences by incorporating emotional feedback, placing human emotion at the core of interactive entertainment.

Commochain

Pre Seed Round in 2019
CommoChain SA is a Swiss company founded in 2018, specializing in a fintech platform that facilitates commodity trading. Headquartered in Plan-les-Ouates, the company focuses on streamlining the back-office operations of exporters and importers of raw materials. By leveraging blockchain and smart contract technology, CommoChain enhances the security and efficiency of financial transactions associated with the international trade of commodities. Its platform aims to simplify, secure, and accelerate the execution of physical transactions, allowing companies to improve their operational efficiency in the global marketplace.

MagicTomato

Venture Round in 2019
MagicTomato operates an online grocery marketplace focused on providing locally sourced and made products. Established in September 2016 in the Geneva area, the company aims to promote sustainable grocery shopping by offering a range of non-industrial and GMO-free items, including fruits, vegetables, meats, cheeses, and beverages. The marketplace features over 800 products sourced from a network of approximately 30 local artisans, ensuring ultimate freshness and quality. MagicTomato's business model emphasizes reducing food waste and packaging, while facilitating same-day delivery to customers. With a commitment to enhancing consumer access to healthy and smart grocery options, the company has achieved break-even status.

Quantum Integrity

Seed Round in 2018
Quantum Integrity SA is a Swiss company based in Geneva, founded in 2017, that specializes in software development for forensic analysis of digital images. The company's technology examines images on a pixel-by-pixel basis to identify manipulations and potential forgeries, regardless of the methods or software employed in their alteration. By focusing on accuracy in forgery detection, Quantum Integrity enhances the security of cyber communications and ensures the integrity of digital media.

Tokenestate.io

Seed Round in 2018
Tokenestate SA is a Swiss-based company that provides a security token issuance and management platform designed for investments in private companies and real estate. Founded in 2017 and located in Geneva, the platform leverages blockchain and digital signature technologies to facilitate fundraising, manage the buying and selling of shares, and conduct KYC and anti-money laundering checks. Additionally, Tokenestate offers Tokenization as a Service (TaaS) for real estate funds, enabling a marketplace for tokenized assets. The company's services streamline the management of securities and enhance the investor experience in the evolving landscape of digital finance.

Kejako

Seed Round in 2018
Kejako SA is a Swiss company, founded in 2015 and based in Plan-les-Ouates, that specializes in the research and development of medical devices for the ophthalmic surgery sector. The company focuses on addressing presbyopia, a condition that leads to the gradual loss of visual accommodation, through innovative solutions. Kejako offers a unique, non-invasive approach that combines simulation and minimally invasive treatment techniques, utilizing a full eye 3D parametric model and multi-physics numerical modeling to accurately compute the eye's optical and mechanical behavior. This technology enables patients to plan and control customized procedures aimed at preserving their quality of life as they age.

CleverDist

Funding Round in 2017
CleverDist is a designer and developer specializing in industrial control systems, primarily serving clients such as CERN. The company focuses on supervisory control and data acquisition systems, integrating control and automation technologies across various industries. Its offerings include a comprehensive range of services related to control systems, such as conceptual design, prototyping, solution architecture, system integration, and supervisory systems. Additionally, CleverDist provides training and staffing services to enhance client capabilities, enabling businesses to implement technology solutions efficiently and profitably.

Alohi

Seed Round in 2017
Alohi is a Swiss company founded in 2015 that offers a cloud-based communication platform tailored for entrepreneurs, small businesses, and individual consumers. The company provides a range of services, including local phone numbers in various countries, customizable greeting messages, call forwarding, voicemail, fax, and announcements. Alohi focuses on two primary platforms: one for self-service communications and another for legally binding electronic signatures. Its current products include Sign.Plus, Fax.Plus, and Scan.Plus, which facilitate electronic signing and verification of documents as well as secure online fax services. By enabling users to communicate efficiently and manage confidential documents safely, Alohi aims to enhance the way individuals and businesses interact.

MagicTomato

Seed Round in 2017
MagicTomato operates an online grocery marketplace focused on providing locally sourced and made products. Established in September 2016 in the Geneva area, the company aims to promote sustainable grocery shopping by offering a range of non-industrial and GMO-free items, including fruits, vegetables, meats, cheeses, and beverages. The marketplace features over 800 products sourced from a network of approximately 30 local artisans, ensuring ultimate freshness and quality. MagicTomato's business model emphasizes reducing food waste and packaging, while facilitating same-day delivery to customers. With a commitment to enhancing consumer access to healthy and smart grocery options, the company has achieved break-even status.

Quantreex

Pre Seed Round in 2017
Quantreex, founded in 2016 and based in Geneva, Switzerland, is a company that develops an AI-based trading platform. This platform enables users to create automated trading strategies quickly by leveraging machine learning and artificial intelligence to identify and exploit market opportunities. The system allows for the verification of financial strategies through backtesting across various instruments and markets, with the ability to implement these strategies live directly on the platform.

Gmelius

Pre Seed Round in 2017
Gmelius Ltd is a software company based in Plan-les-Ouates, Switzerland, founded in 2016. It specializes in developing a plug-and-play email collaboration platform that transforms traditional email inboxes into comprehensive workspaces. Gmelius integrates seamlessly with Google Workspace and connects with other popular tools like Slack and Trello, allowing teams to manage projects and automate workflows without the need for extensive training or data migration. Its features include email tracking, project management, email delegation, shared labels, and Kanban boards, all designed to enhance productivity and collaboration. Gmelius serves over 10,000 paid customers, including notable firms such as Netflix and JustWorks, by facilitating real-time collaboration and unifying internal and external communications directly from email.

ProtonVPN

Seed Round in 2017
ProtonVPN is Swiss-based VPN service, created by the same team of CERN scientists who created ProtonMail. ProtonVPN makes it possible to access the Internet without censorship and surveillance.

TwentyGreen

Seed Round in 2016
TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements aimed at enhancing sustainable animal farming practices. Founded in 2015 and based in Root, Switzerland, the company has developed a unique triple active probiotic product that addresses challenges faced in intensive animal farming, such as improving digestion, enhancing feed conversion ratios, and reducing disease and pollution. The probiotic supplement is grounded in research from the École Polytechnique Fédérale de Lausanne, focusing on the enhancement of gut microbiota, which is crucial for food metabolism and immune defense. Targeting animal farmers, feed suppliers, and large retailers, TwentyGreen aims to capture a 10% share of the rapidly growing global animal feed probiotic market, which exceeds $4 billion annually. The commercialization of their product involves rigorous research and development in collaboration with esteemed academic partners to meet regulatory standards for animal feed.

OrbiWise

Angel Round in 2016
OrbiWise is a Swiss company specializing in advanced technologies for the Internet of Things (IoT) sector. Its primary product, OrbiWAN, is a carrier-grade network server designed for networks utilizing LoRa technology. This server enhances the performance of IoT services by enabling real-time device messaging and targeted device group profiling, effectively supporting a wide range of applications from smart city initiatives to rural and industrial environments. With a strong engineering foundation, OrbiWise's team possesses extensive expertise in wireless technology, cloud and embedded software, communication systems, and RF/hardware design. The company is committed to customer success and values innovation, technology, and integrity in all its operations.

Prodibi

Seed Round in 2016
Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.

IPStock

Seed Round in 2016
The team of IPDM have worked in the Global Stock Image market for over 5 years. They has successfully created the world’s #1 ranked portfolio of vector images Macrovector, world’s most popular cloud service for photographers and artists IPSTOCK.COM, and a premium marketplace for vector illustrations Vectorplace.com. The new IPStock solution is a blockchain ecosystem designed for all marketplaces, content creators and consumers, content registry on blockchain and license management through smart-contracts.

Expedismart

Seed Round in 2016
Expedismart is a courier service comparison platform based in Switzerland that facilitates the sending of mail and parcels both domestically and internationally. The company provides users with the ability to compare various courier services, allowing them to select the most suitable option for their shipping needs. Expedismart's platform emphasizes quality service, accurate booking, and preferred courier times, all while ensuring competitive pricing. By enabling customers to compare prices and book shipments online, Expedismart aims to streamline the shipping process and help individuals and businesses save on their parcel deliveries.

Ifluenz

Seed Round in 2016
Ifluenz is an Instagram influencer marketing platform designed to connect advertisers with influential Instagram users. The company focuses on integrating influencers into campaign planning to ensure that brands and products are authentically represented. By leveraging advanced algorithms, Ifluenz reviews, sorts, and classifies influencers based on various criteria, allowing brands to select the most suitable influencers for their marketing campaigns. This approach facilitates effective product placement and enhances brand visibility, enabling advertisers to promote their offerings to a global audience.

Silver Wave Medical

Seed Round in 2016
Silver Wave is a Swiss company based in Geneva, founded by expert professionals from the pharma & medical device industries. Building on 25 years of experience, the team at Silver Wave has a leading reputation in the field of aesthetics, with experience in research and development as well as manufacturing and management that extends to many global healthcare companies. Silver Wave is built on the team’s experience and passion.

Goodwall

Angel Round in 2015
Goodwall is a social development platform designed for young people, particularly students and recent graduates, to connect over shared interests and explore career opportunities. It serves as a professional social network that caters to the needs of Gen Z and millennials, offering a comprehensive database of over 5 million job and internship listings, as well as more than $1 million in scholarships and awards. The platform not only facilitates access to thousands of volunteer events but also focuses on upskilling young talent by helping them develop essential life skills. Additionally, Goodwall provides a space for users to showcase their professional profiles and receive tailored opportunities based on their skills and aspirations, contributing to their overall career success.

Multiwave Technologies

Seed Round in 2015
Multiwave Technologies AG, headquartered in Geneva, Switzerland with a research and development facility in France, specializes in innovative medical imaging solutions. Established in March 2015, the company is renowned for its leadership in metamaterial MRI antenna design, aiming to enhance the quality of Magnetic Resonance Imaging (MRI) devices. Multiwave Technologies focuses on developing breakthrough MRI and Positron Emission Tomography (PET) devices, with a vision to create portable MRI technology.

Planet Intus

Seed Round in 2015
Planet Intus SA is a Swiss company specializing in the design and development of indoor geolocation software. Founded in 2014 and headquartered in Carouge, Switzerland, the company leverages a combination of French telecommunications expertise and Swiss quality standards. Planet Intus provides both active and passive geolocation infrastructure, enabling a variety of indoor guidance services and applications for end users. Its offerings include preparation and navigation assistance, opportunity tracking, safety services, and marketing data analysis for professionals, enhancing customer experience in sectors such as retail, leisure, travel, and healthcare. The company's innovative 3D-integrated platform utilizes indoor positioning technologies and user behavior analysis, allowing clients to navigate locations like exhibitions efficiently. A team of skilled engineers and technicians supports Planet Intus, focusing on Geographic Information Systems, mobile app development, and big data analytics to deliver superior operational insights and profitability for businesses.

InvestGlass

Seed Round in 2015
InvestGlass is a Swiss-based company founded in 2013, specializing in the development of a web-based platform that provides a comprehensive suite of tools for client and customer management, particularly in the financial sector. The platform integrates features such as digital onboarding, customer relationship management, portfolio management, and marketing automation, all designed to enhance operational efficiency for financial institutions and advisors. InvestGlass also offers a Strategy Tutor to assist investors in maintaining their investment strategies, alongside access to global market data, news, and forecasts. Additionally, an Educational Portal provides resources such as articles, tools, and videos aimed at improving market understanding. By leveraging artificial intelligence and a secure Swiss cloud infrastructure, InvestGlass helps clients navigate compliance challenges while focusing on delivering high-quality investment advice.

Proton Mail

Venture Round in 2015
Proton Mail is a free and secure email service that is powered by community, not surveillance capitalism. Its free plan is supported by paid subscriptions that offer extra features and storage. With Easy Switch, you can quickly migrate from any email provider to Proton Mail. It helps to import emails, labels, contacts, and calendars to Proton Mail and set up automatic forwarding to receive future emails in the new encrypted inbox.

ProtonMail Customer Care

Seed Round in 2015
Protonmail has revolutionized the email industry by providing secure and private email services, ensuring the privacy of its users. The customer support team of Protonmail plays a crucial role in maintaining the trust of the users by providing instant resolutions to their queries. The users can contact the Protonmail support team via email, chat, or the Protonmail Customer Care Number to resolve any issue related to Protonmail. With Protonmail, users can communicate conveniently and securely, leaving no room for data breaches.

Telexoo

Seed Round in 2014
Telexoo is a Geneva-based company that offers an online financial platform for currency exchange at competitive rates. Unlike traditional services, Telexoo provides a more personal approach, allowing users to connect directly with exchange specialists via phone or email, eliminating the need for call centers or ticket systems. Users can create a free account on the platform to transfer funds from their bank for exchange. The transactions are executed in real-time based on the interbank rate, enabling users to send exchanged currency seamlessly to any destination. Telexoo focuses on providing accessible and efficient currency exchange services.

Aptissen

Seed Round in 2014
Aptissen SA, founded in 2013 as a spin-off of ANTEIS, is a Swiss company based in Plan-les-Ouates, specializing in the development and commercialization of hyaluronic acid polymer-based injectable medicinal products. The company focuses on aesthetic medicine, ophthalmology, and orthopedics, with notable innovations such as the Synolis VA range, which combines hyaluronic acid and sorbitol to provide rapid mobility recovery and effective pain relief for osteoarthritis patients. Aptissen also offers a food supplement called Cartylis aimed at joint health. Its products are distributed through a global network of distributors in over 50 countries, including Europe, South America, Canada, the Middle East, and Asia. The company operates subsidiaries in Italy, Poland, and France, and maintains certifications including CE, ISO13485, MDSAP, and GMP compliance, ensuring adherence to high-quality standards. Aptissen relies on subcontracting for production, sourcing materials from three suppliers located in Europe.

nyce

Seed Round in 2014
nyce is a disruptive online Art Gallery collaborating with pioneering Artists producing their debut Art sculptures while exploring new territories.

CleverDist

Seed Round in 2014
CleverDist is a designer and developer specializing in industrial control systems, primarily serving clients such as CERN. The company focuses on supervisory control and data acquisition systems, integrating control and automation technologies across various industries. Its offerings include a comprehensive range of services related to control systems, such as conceptual design, prototyping, solution architecture, system integration, and supervisory systems. Additionally, CleverDist provides training and staffing services to enhance client capabilities, enabling businesses to implement technology solutions efficiently and profitably.

Faveeo

Seed Round in 2013
Faveeo SA, established in 2012 and headquartered in Geneva, Switzerland, specializes in collaborative intelligence solutions for large organizations. The company offers an integrated suite of tools designed to manage internal and external data streams effectively. Faveeo's platform automatically identifies key concepts, sources, and people relevant to any topic or industry, facilitates content curation and analysis, and enables seamless collaboration and publishing. Its solutions are employed for media monitoring, competitive intelligence, market research, social media engagement, and content marketing applications across various sectors, including research centers, NGOs, and international groups.

ProtonMail Customer Care

Grant in 2013
Protonmail has revolutionized the email industry by providing secure and private email services, ensuring the privacy of its users. The customer support team of Protonmail plays a crucial role in maintaining the trust of the users by providing instant resolutions to their queries. The users can contact the Protonmail support team via email, chat, or the Protonmail Customer Care Number to resolve any issue related to Protonmail. With Protonmail, users can communicate conveniently and securely, leaving no room for data breaches.

V-Labs

Seed Round in 2013
V-Labs is a technology company specializing in augmented reality solutions for excavation projects. It develops advanced augmented reality technology tailored for geospatial headsets, allowing users to visualize complex data directly at the worksite with centimeter accuracy. This innovative approach includes a local positioning system that enhances operational efficiency by minimizing risks of damage to underground infrastructure. By providing real-time visual guidance, V-Labs enables operators and contractors to expedite excavation processes while ensuring safety and precision in their work.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.